TUKYSA: payments to doctors
Payments that named TUKYSA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $6.6M
- Providers
- 11,426
- Transactions
- 56,936
- Average per transaction
- $116
The per-transaction average — $116 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 11,426 providers the average total is $579, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Seagen Inc. | $5,309,352 | 80.3% |
| Pfizer | $1,137,724 | 17.2% |
| Array Biopharma Inc | $149,345 | 2.3% |
| Whitehall International Inc | $14,459 | 0.2% |
| PBG Puerto RICO LLC | $2,390 | 0.0% |